NCT06040970: Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 54 planned
- Started
- 28 Oct 2024
- Primary completion
- 1 Jul 2031
- Arms
- Ovarian cancer Cohort, Endometrial cancer Cohort
- Results
- None posted
- 18 Sep 2023: Trial registered
- 28 Oct 2024: Trial started